Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.

CONTEXT Experimental studies suggest that aldosterone induces hypercalciuria and might contribute to hyperparathyroidism. OBJECTIVE We aimed to test for differences in PTH levels and parameters of calcium and vitamin D metabolism in patients with primary aldosteronism (PA) compared with patients with essential hypertension (EH) and to evaluate the impact of PA treatment on these laboratory values. DESIGN, SETTING, AND PARTICIPANTS The Graz Endocrine Causes of Hypertension study includes hypertensive patients referred for screening for endocrine hypertension at a tertiary care center in Graz, Austria. MAIN OUTCOME MEASURES Differences in PTH levels between patients with PA and EH. RESULTS Among 192 patients, we identified 10 patients with PA and 182 with EH. PTH levels (mean ± sd in picograms per milliliter) were significantly higher in PA patients compared with EH (67.8 ± 26.9 vs. 46.5 ± 20.9; P = 0.002). After treatment of PA with either adrenal surgery (n = 5) or mineralocorticoid receptor antagonists (n = 5), PTH concentrations decreased to 43.9 ± 14.9 (P = 0.023). Serum 25-hydroxyvitamin D concentrations were similar in both groups. Compared with EH, serum calcium concentrations were significantly lower (2.35 ± 0.10 vs. 2.26 ± 0.10 mmol/liter; P = 0.013), and there was a nonsignificant trend toward an increased spot urine calcium to creatinine ratio in PA [median (interquartile range) 0.19 (0.11-0.31) vs. 0.33 (0.12-0.53); P = 0.094]. CONCLUSIONS Our results suggest that PA contributes to secondary hyperparathyroidism. Further studies are warranted to evaluate whether PTH has implications for PA diagnostics and whether mineralocorticoid receptor antagonists have a general impact on PTH and calcium metabolism.

[1]  W. März,et al.  Aldosterone and Parathyroid Hormone: A Complex and Clinically Relevant Relationship , 2010, Calcified Tissue International.

[2]  W. März,et al.  Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. , 2010, European heart journal.

[3]  A. Ayav,et al.  Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. , 2009, Surgery.

[4]  C. Held,et al.  Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community , 2009, Circulation.

[5]  T. Pieber,et al.  Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism , 2009, BMC endocrine disorders.

[6]  L. Carbone,et al.  Fracture risk in men with congestive heart failure risk reduction with spironolactone. , 2008, Journal of the American College of Cardiology.

[7]  L. Carbone,et al.  Secondary Hyperparathyroidism in Patients with Untreated and Treated Congestive Heart Failure , 2006, The American journal of the medical sciences.

[8]  K. Weber,et al.  Diuretics and bone loss in rats with aldosteronism. , 2005, Journal of the American College of Cardiology.

[9]  K. Weber,et al.  Bone Loss in Rats with Aldosteronism , 2005, The American journal of the medical sciences.

[10]  P. Milliez,et al.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. , 2005, Journal of the American College of Cardiology.

[11]  K. Weber,et al.  70 HYPERPARATHYROIDISM AND THE CALCIUM PARADOX OF ALDOSTERONISM , 2005, Journal of Investigative Medicine.

[12]  P. Miccoli,et al.  Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery. , 1999, Metabolism: clinical and experimental.

[13]  L. Kovács,et al.  The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism. , 1998, European journal of endocrinology.

[14]  C. Dotti,et al.  Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. , 1995, American journal of hypertension.

[15]  G. Colussi,et al.  Hypercalcemia in Addison's disease: calciotropic hormone profile and bone histology , 1992, Journal of internal medicine.

[16]  J. Laragh,et al.  Calcium metabolism and parathyroid function in primary aldosteronism. , 1985, The American journal of medicine.

[17]  A. Barkan,et al.  Primary hyperparathyroidism: possible cause of primary hyperaldosteronism in a 60-year-old woman. , 1980, The Journal of clinical endocrinology and metabolism.

[18]  W. Suki,et al.  Effect of chronic mineralocorticoid administration on calcium excretion in the rat. , 1968, The American journal of physiology.

[19]  K. Weber,et al.  Calcium paradox of aldosteronism and the role of the parathyroid glands. , 2006, American journal of physiology. Heart and circulatory physiology.

[20]  S. Gonnelli,et al.  Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. , 1995, Mineral and electrolyte metabolism.

[21]  K. O̸lgaard,et al.  Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone. , 1994, Mineral and electrolyte metabolism.